The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of a phase II study of MRI based functional imaging of bone metastases in men with metastatic castrate-resistant prostate cancer (mCRPC) receiving Cabozantinib.
 
Arpita Desai
No Relationships to Disclose
 
Jamie Renee Brewer
No Relationships to Disclose
 
Milica Medved
No Relationships to Disclose
 
Aytekin Oto
Honoraria - Bracco Diagnostics
Consulting or Advisory Role - Profound Healthcare
Research Funding - Guerbet; Philips Healthcare; Profond Healthcare
Travel, Accommodations, Expenses - Bracco Diagnostics
 
Guimin Gao
No Relationships to Disclose
 
Theodore Karrison
No Relationships to Disclose
 
Daniel H. Shevrin
Speakers' Bureau - Bayer
 
Greg S. Karczmar
No Relationships to Disclose
 
Walter Michael Stadler
Honoraria - AstraZeneca; Bristol-Myers Squibb; CVS Caremark; Sotio
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; CVS Caremark; Eisai; Pfizer; Roche/Genentech; Sotio
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Johnson & Johnson (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); X4 Pharma (Inst)
Other Relationship - American Cancer Society; UpToDate
 
Russell Zelig Szmulewitz
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Exelixis; Janssen Oncology; Merck; Pfizer; Sanofi
Research Funding - Abbvie; Astellas Pharma; Incyte; Janssen Oncology; Macrogenics
Patents, Royalties, Other Intellectual Property - Patent licensed by University of Chicago of which I am co-inventor to Corcept Therapeutics for combination AR/GR inhibition in prostate cancer
Travel, Accommodations, Expenses - Corcept Therapeutics